Ron Squarer
CIK 1454001 · CEO · last filed 2026-06-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.54M
Companies
6
Total Filings
52
Lifetime Open-Market Net
-$1.72M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ADCT | Director | 138,627 | $1.05 | $145.6K | -$20.2K | 5 | 2026-06-03 |
| TVTX | Director | 39,375 | $52.04 | $2.05M | $0 | 6 | 2026-05-21 |
| NUVL | Director | 2,837 | $123.25 | $349.7K | $0 | 1 | 2025-12-11 |
| Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Director | — | $25.59 | — | $0 | 12 | 2024-06-11 |
| Travere Therapeutics, Inc. (RTRX) Delisted | Director | 11,875 | — | — | $0 | 4 | 2020-05-19 |
| HOSPIRA INC (HSP) Delisted | Chief Commercial Officer | 19,563 | — | — | -$1.70M | 6 | 2011-02-28 |
Recent Filings · Page 4 of 6
52 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-12-18 | — | Mixed | +27,134 | -$340.2K | |
| 2018-06-29 | — | Mixed | — | -$2.71M | |
| 2018-05-11 | Travere Therapeutics, Inc. (RTRX) Delisted | Grant (A) | +2,500 | $0 | EDGAR |
| 2018-04-03 | — | Mixed | +2,301 | -$271.0K | |
| 2017-12-19 | — | Mixed | +93,591 | -$4.04M | |
| 2017-04-12 | Travere Therapeutics, Inc. (RTRX) Delisted | Grant (A) | +4,375 | $0 | EDGAR |
| 2017-04-06 | — | Tax (F) | −17,563 | -$157.0K | |
| 2017-04-04 | — | Mixed | +6,864 | -$107.7K | |
| 2016-12-29 | — | Grant (A) | — | $0 | |
| 2016-04-05 | — | Mixed | −5,878 | -$17.6K |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.